Franz Obermayr
Algemeen Directeur bij Panoptes Pharma GmbH
Actieve functies van Franz Obermayr
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Algemeen Directeur | 01-07-2013 | - |
| Oprichter | 01-07-2013 | - |
Loopbaan van Franz Obermayr
Eerdere bekende functies van Franz Obermayr
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Algemeen Directeur | 01-02-2021 | 26-07-2021 |
| Hoofd Techniek/Wetenschap/O&O | 18-12-2020 | 31-12-2021 | |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 01-01-2009 | 01-01-2013 |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Oostenrijk | 2 |
| Ierland | 2 |
Operationeel
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectoraal
| Health Technology | 4 |
| Retail Trade | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
- Beurs
- Insiders
- Franz Obermayr
- Ervaring
